Predominance of CD137+ And TNF-α Expressing CD8+ Central Memory T Cells in Mild COVID-19 Recovered Patients Upon SARS-CoV-2 Re-Exposure

Immunol Invest. 2024 Oct;53(7):1092-1101. doi: 10.1080/08820139.2024.2376003. Epub 2024 Jul 12.

Abstract

Introduction: Memory CD8+ T cells are essential for long-term immune protection in viral infections, including COVID-19.

Methods: This study examined the responses of CD8+ TEM, TEMRA, and TCM subsets from unvaccinated individuals who had recovered from mild and severe COVID-19 by flow cytometry.

Results and discussion: The peptides triggered a higher frequency of CD8+ TCM cells in the recovered mild group. CD8+ TCM and TEM cells showed heterogeneity in CD137 expression between evaluated groups. In addition, a predominance of CD137 expression in naïve CD8+ T cells, TCM, and TEM was observed in the mild recovered group when stimulated with peptides. Furthermore, CD8+ TCM and TEM cell subsets from mild recovered volunteers had higher TNF-α expression. In contrast, the expression partner of IFN-γ, IL-10, and IL-17 indicated an antiviral signature by CD8+ TEMRA cells. These findings underscore the distinct functional capabilities of each memory T cell subset in individuals who have recovered from COVID-19 upon re-exposure to SARS-CoV-2 antigens.

Keywords: COVID-19; Central memory T cells; Immunological memory; SARS-CoV-2 infection; effector memory T cells.

MeSH terms

  • Adult
  • CD8-Positive T-Lymphocytes* / immunology
  • COVID-19* / immunology
  • Female
  • Humans
  • Immunologic Memory / immunology
  • Male
  • Memory T Cells* / immunology
  • Middle Aged
  • SARS-CoV-2* / immunology
  • Tumor Necrosis Factor Receptor Superfamily, Member 9* / immunology
  • Tumor Necrosis Factor Receptor Superfamily, Member 9* / metabolism
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Tumor Necrosis Factor Receptor Superfamily, Member 9
  • Tumor Necrosis Factor-alpha